Pneumococcal polysaccharide-protein conjugate (PCV)

Pneumococcal polysaccharide-protein conjugates are the active pharmacological components of modern pneumococcal conjugate vaccines (PCVs) used to prevent invasive and non-invasive diseases caused by Streptococcus pneumoniae [CDC, 2022]. These molecules consist of purified capsular polysaccharides from specific pneumococcal serotypes that are chemically linked to a carrier protein, most frequently CRM197 [StatPearls, 2023]. This conjugation is essential because pure polysaccharides are T-cell independent antigens that fail to elicit a robust immune response or immunological memory in infants and young children [WHO, 2019]. By utilizing a protein carrier, the vaccine recruits T-helper cells to facilitate a high-affinity IgG antibody response and the creation of memory B-cells [PubMed, 2021]. PCVs have been highly effective in reducing the global incidence of pneumonia, meningitis, and febrile bacteremia by targeting the serotypes most commonly associated with severe disease [NIH, 2020]. Continuous development of these conjugates aims to expand serotype coverage to address the challenge of serotype replacement [FDA, 2024].

Other names

Pneumococcal conjugate vaccinePCVStreptococcus pneumoniae polysaccharide-protein conjugateGlycoconjugate vaccinePneumococcal capsular polysaccharide-carrier protein conjugate

The conjugate acts by converting T-cell independent capsular polysaccharide antigens into T-cell dependent antigens [PubMed, 2018]. By covalently linking the polysaccharide to a carrier protein (such as CRM197, a non-toxic mutant of diphtheria toxin, or tetanus toxoid), the complex is internalized by B-cells via surface immunoglobulin receptors. The protein component is then processed and presented via MHC class II molecules to T-helper cells [StatPearls, 2023]. This T-cell help stimulates B-cell proliferation, isotype switching from IgM to IgG, affinity maturation, and the differentiation of B-cells into long-lived memory B-cells and plasma cells, which provide durable protection and mucosal immunity [WHO, 2019].